Gaudia, Ma. Lorein P.

HRN: 24-88-46  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/19/2024
CEFUROXIME 750MG (VIAL)
04/19/2024
04/26/2024
IV
750mg
Q8H
PCAP C
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: